| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0664d576dcbe5ff142f93d6b4615d198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e03da4246584f21c2535604e34d40a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10f95c632a93581ef5462cb871f13212 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 |
| filingDate |
2001-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca18461127b51741053c1c9038f9d2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62ec1cef023215ce6ab5a1d3ef326626 |
| publicationDate |
2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0216608-A1 |
| titleOfInvention |
New sequences |
| abstract |
A nucleic acid molecule which interacts with reverse transcriptase of a retrovirus. The nucleic acid molecule comprises a nucleotide sequence essentially composed of two stem-loop structures and a short bridge between the two stems, which molecule for the purposes of the interaction with reverse transcriptase is analogous to the dihydrouridine (D) -stem-loop and anticodon (A) -stem-loop of a mammalian transfer RNA (tRNA). Optionally, in the nucleic acid molecule, some or all of the normal phosphodiester nucleoside linkages have been substituted with phosphorothioate linkages. The invention further relates to the use of said nucleic acid molecule for the manufacture of a medicament for the inhibition of the interaction of HIV-1 and HIV-2 reverse transcriptase with tRNALys3. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009038666-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4174179-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431341-B2 |
| priorityDate |
2000-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |